Training workshops on flow cytometry in Africa
Official title: Flow Cytometry Workshops in Africa
Funded at Fred Hutchinson Cancer Center · NIH-11085509 · Data updated 2026-11-12
This study is all about helping African scientists and immunologists learn how to use a special tool called flow cytometry to better understand and research diseases like HIV, tuberculosis, and malaria, so they can improve health in their communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | December 1, 2024 |
| Project end | November 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $25,000 |
| NIH project number | 1R13AI189265-01 |
| Project ID | NIH-11085509 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are African immunologists and scientists working in fields related to infectious diseases and cancer biology.
✕Less likely to help
Patients who are not involved in scientific research or do not have access to flow cytometry technology may not benefit from this research.
What this research studies
This research focuses on providing advanced training in flow cytometry, a technology used to analyze cells, to African scientists and immunologists. The workshops aim to enhance both theoretical knowledge and practical skills, enabling participants to effectively use this technology in their research on diseases prevalent in Africa, such as HIV, tuberculosis, and malaria. By offering these workshops, the project seeks to build local expertise and improve the quality of scientific studies conducted in resource-limited settings. The training is designed to be intensive yet accessible, allowing participants to gain competency in a relatively short time frame.
Why it matters
Potential benefit: If successful, this research could significantly improve the capacity of African scientists to conduct critical health research using advanced flow cytometry techniques.
How similar studies have gone: Previous workshops have successfully trained scientists in flow cytometry, indicating that this approach has proven effective in enhancing local research capabilities.
Where this research is happening
-
Fred Hutchinson Cancer Center
Seattle, United States Active
Researchers
- Principal investigator: Andersen-Nissen, Erica — Fred Hutchinson Cancer Center
- Study coordinator: Andersen-Nissen, Erica
Related research
Other NIH-funded projects on the same topics.
-
How brain glia prune neuron fragments in a worm model
Researchers study how brain support cells called glia remove pieces of living neurons in a tiny worm to learn about brain aging and diseases like Alzheimer's.
-
Understanding and Targeting Lineage Plasticity in Prostate Cancer with Genomic-Based Neoadjuvant Therapy
A broad research program at Fred Hutchinson Cancer Center is exploring how aggressive prostate cancers change their cell states in response to therapy and how to block these changes.
-
Personalized cancer drug testing on patient tumor cells
Aiming to test many FDA-approved cancer drugs on a patient’s own tumor cells to identify effective options when standard therapies fail.
-
MOSAAIC: Using health records to track heart disease in Asian American Communities
A big, dedicated effort is testing whether electronic health records can more quickly and accurately track heart and blood vessel problems in Asian American populations.
-
Targeting gut microbes to prevent progression to multiple myeloma
Researchers are testing how specific gut bacteria might trigger immune changes linked to early blood cancer stages and whether targeting these microbes could help prevent progression to multiple myeloma.
-
eDyNAmiC: Understanding extrachromosomal DNA in cancer and how it drives aggressiveness
A cancer research project at Fred Hutchinson Cancer Center is studying abnormal circular DNA pieces (ecDNA) that help cancers grow and resist treatment, with the aim of finding ways to help patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.